Managed Care and the Pharmaceutical Industry - Top Issues, Health Care Reform and the Inter-linkages Bringing them Together

CBR Pharma Insights, LLC
December 1, 2010
SKU: CBRP6428951
Managed Care and the Pharmaceutical Industry - Top Issues, Health Care Reform and the Inter-linkages Bringing them Together

  enlarge
The managed care and the pharmaceutical industries have many conflicting goals. Managed care organizations are looking to reduce or - at the least - maintain drug costs, while pharmaceutical companies seek to increase the sale of their brand-name drugs. Common ground between the two industries can be difficult to find.

Shared goals do exist, though. Both the managed care industry and the pharmaceutical industry have a stake in how prescription drugs impact the cost and quality of health care. Both industries would like to see treatment persistence increase and, to this end, are continually investing in the research and development of disease management and medication compliance programs. Finally, both the managed care and the pharmaceutical drug industry are heavily influenced by the each other as well as other health care stakeholders, such as the Federal and state governments, health care providers and practitioners, and consumers.

This consultancy-style report provides an overview of the top issues in the managed care market and examines how the pharmaceutical industry, and other health care stakeholders, affect and are affected by the growth of managed care in the US market.

Please Note: This product is delivered as a zip file


Additional Information

Reasons to Purchase
  • Gain access to a fully sourced, executive assessment of the current state of the managed care industry
  • Benefit from CBR’s evaluation of the inter-linkages between the key components of the US health care environment
  • Understand the key issues facing managed care and where the pharmaceutical industry could support its relationship with its main health care partners moving forward
  • Assess what the future of managed care holds for the pharmaceutical industry and where opportunities may exist to support your company’s growth moving forward

    More Manufacturing, Packaging & Detailing reports by CBR Pharma Insights, LLC

    The Politics of Pharma (CBRSV042) – Washington, States, and the Courts Impact on the Industry by CBR Pharma Insights, LLC
    Politics have a greater direct effect on the pharmaceutical industry than almost any other in the US, and correspondingly, pharma makes considerable investments in election ...
    Clinical Development and Trial Design – Developing a Coherent Approach from Beginning to End by CBR Pharma Insights, LLC
    A good clinical development plan will ensure success throughout the product lifecycle. In today’s cost constrained environment, the clinical development plan can help ...
    Diversification in the Pharmaceutical Industry – Essential For Survival or an Unnecessary Distraction? by CBR Pharma Insights, LLC
    Pharmaceutical companies face the dual threats of industry specific difficulties driven by the innovation crisis, patent expiries and healthcare reform, coupled with the more generalized ...
    The Payer Landscape in the United States – The Pharmaceutical Industry Faces a Rapidly Changing Marketplace by CBR Pharma Insights, LLC
    Managed care began to be developed as early as 1917, with both private and government payers established by the mid-1960s. Medicare and Medicaid are the ...
    See all reports like this >>

     

    SELECT A LICENSE

        Online Download  USD 3,900  
        Global Site License  USD 9,800  
     
    US: 800.298.5699
    Int'l: +1.240.747.3093
     

    Share this report


      Other tasks

       
       
      Join Alert Me now!
      Receive bi-weekly email alerts on new market research

      Sign up today!